JPRN-UMIN000050415RecruitingUnknown
Study aiming for individualized pharmacotherapy based on genetic polymorphism for cognitive decline in elderly breast cancer patients. - Study aiming for individualized pharmacotherapy based on genetic polymorphism for cognitive decline in elderly breast cancer patients
Aichi Cancer Center Hospital0 sites100 target enrollmentStarted: February 22, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 70years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Person who has serious organ dysfunction and cannot receive chemotherapy treatment 2) A person who has judged that incorporation into research is inappropriate
Investigators
Similar Trials
Completed
Not Applicable
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10
Not yet recruiting
Phase 1
Clinical study of Darvyadi Granules in Iron Deficiency Anaemia.CTRI/2020/04/024459Parul University
Not yet recruiting
Phase 3
Arka dosage form of shweta Aparajita roots in management of Primary Hypothyroidism as add on along with Thyroxine.CTRI/2024/07/070645Dr Jayshree Hadke
Active, not recruiting
Phase 3
Clinical study to assess how well wilate works in the regular treatment of young children with severe von Willebrand diseaseISRCTN11217735Octapharma (Austria)12
Unknown
Phase 1
Clinical pharmacology study to investigate the food effect on pharmacokinetics of TAS-102.Patients with solid tumorJPRN-jRCT2080221443Taiho Pharmaceutical Co., Ltd.16